Influence of Acupoint Application on P Substance,Immunoglobin E and Interferon-γ in Patients with Lung Qi Deficient Bronchial Asthma: Based on Winter Disease Treated in Summer
LI Bolin, WANG Yali, ZHANG Mingquan, et al. Influence of Acupoint Application on P Substance,Immunoglobin E and Interferon-γ in Patients with Lung Qi Deficient Bronchial Asthma: Based on Winter Disease Treated in Summer[J]. Journal of Traditional Chinese Medicine2015, 56(15): 1311-1313.
LI Bolin, WANG Yali, ZHANG Mingquan, et al. Influence of Acupoint Application on P Substance,Immunoglobin E and Interferon-γ in Patients with Lung Qi Deficient Bronchial Asthma: Based on Winter Disease Treated in Summer[J]. Journal of Traditional Chinese Medicine2015, 56(15): 1311-1313.DOI: 10.13288/j.11-2166/r.2015.15.014.
Objective To investigate the possible mechanism of acupoint application in treating bronchial asthma. Methods Fifty patients with lung qi deficient bronchial asthma received acupoint application in dog days.One treatment was given in a dog day
altogether three times. Fifty healthy volunteers were enrolled as control group.The concentrations of serum immunoglobin E( Ig E)
interferon-γ( IFN-γ) and plasma P substance( SP) before and after treatment were detected in both control and asthma group. The correlations of Ig E
IFN-γ and SP before and after treatment in patients with asthma were analyzed using Pearson correlation analysis. Results Before the treatment
concentrations of serum Ig E
IFN-γ and plasma SP in patients with asthma had statistical differences with those in control( P < 0. 05). Concentrations of serum Ig E
IFN-γ and plasma SP in patients with asthma before and after treatment were significantly different( P < 0. 05). Ig E was positively correlated with SP and negatively correlated with IFN-γ in patients with asthma before treatment( P < 0. 05). However
there was no relationship between SP and IFN-γ( P > 0. 05). There were also no significant relationships between Ig E
IFN-γ and SP after treatment( P > 0. 05).Conclusion Acupoint application based on winter disease treated in summer can improve immune function by regulating secretion of cytokine and release of neurotransmitter
leading to therapeutic effect in bronchial asthma.